Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2568708 | 0.85 | ADORA3 (0.37) | ALOX12ADORA3ADORA2AADORA2BMGLL | |
| SCHEMBL30852785 | 0.82 | ALDH1A1 (0.55) | ALOX12SMN1; SMN2KMT2APOLB | |
| SCHEMBL14238731 | 0.82 | ALDH1A1 (0.55) | ALOX12SMN1; SMN2KMT2APOLB | |
| SCHEMBL12743131 | 0.82 | ADORA3 (0.33) | ALOX12ADORA3ADORA2AADORA2BMGLL | |
| SCHEMBL2610829 | 0.82 | ADORA3 (0.36) | ADORA3ADORA2AADORA2BMGLLSMN1; SMN2 | |
| SCHEMBL12955277 | 0.82 | TSHR (0.34) | ADORA3ADORA2AADORA2BMGLLTSHR | |
| SCHEMBL13323678 | 0.82 | ADORA3 (0.33) | ADORA3ADORA2AADORA2BMGLL | |
| SCHEMBL43576 | 0.80 | PSMB8 (0.35) | ALOX12ADORA3ADORA2AADORA2BMGLL | |
| SCHEMBL2618714 | 0.80 | MGLL (0.34) | ALOX12ADORA3ADORA2AADORA2BMGLL | |
| SCHEMBL24621700 | 0.80 | ADORA3 (0.33) | ALOX12ADORA3ADORA2AADORA2BMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994682-B2 | Polymers and process for making membranes | APPLIED BIOMIMETIC A/S (DK) | 2018-06-12 | — | — | US | disclosed |
| US-20170166704-A1 | NOVEL POLYMERS AND PROCESS FOR MAKING MEMBRANES | APPLIED BIOMIMETIC A/S (DK) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166704-A1 | NOVEL POLYMERS AND PROCESS FOR MAKING MEMBRANES | CHMP4B, VAMP7, VAPB | ALOX12 2289/4885ADORA3 3504/4885ADORA2A 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.